Page last updated: 2024-11-02

pentoxifylline and Carcinoma, Hepatocellular

pentoxifylline has been researched along with Carcinoma, Hepatocellular in 7 studies

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"To investigate the effects of pentoxifylline (PTX) on radiation induced-cell cycle redistribution and radiosensitivity of human hepatocellular carcinoma cell line Hep3b."3.73[Cytotoxicity of pentoxifylline and its effect on human hepatoma cell line Hep3b radiosensitivity]. ( Chen, LH; Liu, L; Wu, DH, 2006)
"Pentoxifylline (PTX) is a methylxanthine derivative and has potent anti-tumor activity."1.46Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling. ( Dong, L; Li, J; Luo, M; Shang, B; Wang, Y, 2017)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Y1
Dong, L1
Li, J1
Luo, M1
Shang, B1
Jiménez-Luévano, MÁ1
Rodríguez-Chávez, JL1
Ramírez-Flores, S1
Rodríguez-Villa, P1
Jiménez-Partida, MÁ1
Cervantes-Rodríguez, G1
Hernández-Flores, G1
Solís-Martínez, R1
Bravo-Cuellar, A1
Jang, MS1
Baek, JW1
Kang, DY1
Kang, JS1
Suh, KS1
Kim, ST1
Wu, DH2
Liu, L2
Chen, LH2
Costelli, P1
Almendro, V1
Figueras, MT1
Reffo, P1
Penna, F1
Aragno, M1
Mastrocola, R1
Boccuzzi, G1
Busquets, S1
Bonelli, G1
Lopez Soriano, FJ1
Argilés, JM1
Baccino, FM1
Wördemann, M1
Fandrey, J1
Jelkmann, W1

Other Studies

7 other studies available for pentoxifylline and Carcinoma, Hepatocellular

ArticleYear
Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
    Life sciences, 2017, Aug-15, Volume: 183

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Prolif

2017
Treatment of hepatocarcinoma with celecoxib and pentoxifylline: a case report
    Revista medica del Instituto Mexicano del Seguro Social, 2018, Oct-25, Volume: 56, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Ce

2018
Supraumbilical skin rash after transcatheter arterial chemoembolization: successful treatment with pentoxifylline.
    The Journal of dermatology, 2011, Volume: 38, Issue:12

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Exanthema; Female; Hepatic Artery; Humans

2011
[Radiosensitization by pentoxifylline in human hepatoma cell line HepG2 and its mechanism].
    Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2004, Volume: 24, Issue:4

    Topics: Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Cell Line, Tumor; DNA Damage; Genes, p53; Huma

2004
[Cytotoxicity of pentoxifylline and its effect on human hepatoma cell line Hep3b radiosensitivity].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2006, Volume: 26, Issue:3

    Topics: Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; D

2006
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy.
    Biochimica et biophysica acta, 2007, Volume: 1770, Issue:7

    Topics: Animals; Blotting, Western; Cachexia; Calcineurin; Carcinoma, Hepatocellular; DNA; DNA Primers; Elec

2007
Tumor necrosis factor-alpha production by human hepatoma cell lines is resistant to drugs that are inhibitory to macrophages.
    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 1998, Volume: 18, Issue:12

    Topics: Adjuvants, Immunologic; Carcinoma, Hepatocellular; Cyclosporine; Drug Resistance, Neoplasm; Humans;

1998